Stock · NSE
AUROPHARMA
1,564.70▼ 22.70 (-1.43%)Last 2 days · 15m candles10/7/2026, 21:18:06
Open: 1,588.80High: 1,588.80Low: 1,546.00Prev: 1,587.40
News mentioning AUROPHARMA
VERIFIEDEconomic Times News·4d★ ON YOUR LIST
LKP Securities’ top 3 picks: High-conviction breakout stocks targeting strong gainsAI summary· POSITIVE
- ·LKP Securities has identified Aegis Vopak, Lodha, and Aurobindo Pharma as short-term stock picks.
- ·The selections are based on strong technical indicators such as chart breakouts and bullish RSI crossovers.
- ·Positive market sentiment is currently supporting selective stock opportunities.
VERIFIEDET Markets·6d★ ON YOUR LIST
F&O Talk: Smallcap index better placed than Nifty, says Sudeep Shah; picks 9 stocks for next weekAI summary· POSITIVE
- ·SBI Securities anticipates Nifty's breakout to strengthen if it crosses 24,450, potentially reaching 24,900.
- ·Small-cap stocks continue to show outperformance, and Bank Nifty maintains a positive outlook.
- ·Aurobindo Pharma, DLF, Titan, and Oberoi Realty are highlighted as top stock picks.
VERIFIEDEconomic Times News·6d★ ON YOUR LIST
F&O Talk: Smallcap index better placed than Nifty, says Sudeep Shah; picks 9 stocks for next weekAI summary· NEUTRAL
- ·SBI Securities anticipates Nifty's breakout strengthening if it surpasses 24,450, potentially reaching 24,900.
- ·Small-cap stocks continue to exhibit outperformance.
- ·Aurobindo Pharma, DLF, Titan, and Oberoi Realty are among the highlighted stock picks.
VERIFIEDMint Markets·9d★ ON YOUR LIST
Aurobindo Pharma’s investors await next leg of growthAI summary· NEUTRAL
- ·Aurobindo Pharma's growth is expected to be supported by the Pen-G project ramp-up.
- ·Integration of Lannett and new US product launches are anticipated to aid growth.
- ·Expansion in Europe and contributions from higher-margin businesses are also expected to drive growth.
VERIFIEDET Stocks·11d★ ON YOUR LIST
Aurobindo Pharma among 9 mid-cap stocks to hit 52-week highs & rally up to 20% in a monthAI summary· POSITIVE
- ·Nine BSE Midcap stocks reached new 52-week highs on Monday.
- ·Aurobindo Pharma was among the mid-cap stocks that hit 52-week highs.
- ·Bank of Maharashtra, Thermax, Bharat Forge, Oracle Financial Services, and Laurus Labs were notable outperformers.
VERIFIEDET Markets·11d★ ON YOUR LIST
Aurobindo Pharma among 9 mid-cap stocks to hit 52-week highs & rally up to 20% in a monthAI summary· POSITIVE
- ·Nine BSE Midcap stocks reached new 52-week highs on Monday.
- ·Aurobindo Pharma was among the mid-cap stocks that hit 52-week highs.
- ·Bank of Maharashtra, Thermax, Bharat Forge, Oracle Financial Services, and Laurus Labs were noted outperformers.
VERIFIEDEconomic Times News·11d★ ON YOUR LIST
Nifty has more room to run; stay selective: AnalystsAI summary· NEUTRAL
- ·Nifty is targeting the 24,300-25,000 zone amidst market volatility.
- ·Analysts suggest selective trading and strategies like a moderately bullish Call Spread.
- ·Recommended stocks include TVS Motor, Samvardhana Motherson International, Oberoi Realty, Aurobindo Pharma, Vijaya Diagnostic Centre, and Mahindra & Mahindra Financial Services.
Google News, India stocks·12d★ ON YOUR LIST
Stocks to Watch Today: Kotak Bank, Torrent Power, Persistent, Aurobindo Pharma, Dr Reddys Labs, KEC... - Moneycontrol.comVERIFIEDET Finance·17d★ ON YOUR LIST
Indian pharma firms gear up to supply key cancer drug to USAI summary· NEUTRAL
- ·Indian drugmakers are preparing to supply ifosfamide injection to the US.
- ·Zydus, Cipla, Alkem, and Aurobindo Pharma are in discussions to provide the chemotherapy drug.
- ·The US FDA has contacted Indian pharmaceutical bodies to find manufacturers for the drug.
VERIFIEDET Finance·18d★ ON YOUR LIST
Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett CompanyAI summary· POSITIVE
- ·Aurobindo Pharma's US subsidiary received Federal Trade Commission approval for the $250 million acquisition of Lannett Company.
- ·The acquisition is anticipated to be finalized by June 2026.
- ·The deal is expected to enhance Aurobindo's complex generics and controlled substances offerings and immediately increase earnings per share.
VERIFIEDET Finance·21d★ ON YOUR LIST
Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soonAI summary· POSITIVE
- ·Aurobindo Pharma has received antitrust clearance from the US Federal Trade Commission for its takeover of Lannett Company.
- ·This regulatory approval removes the final hurdle for the acquisition.
- ·The acquisition is expected to close by the end of June.
VERIFIEDET Finance·22d★ ON YOUR LIST
US FTC imposes divestment condition on Aurobindo Pharma's $250 mn Lannett acquisitionGoogle News, India stocks·26d★ ON YOUR LIST
Stocks to Watch Today: NLC India, Dr Reddys Labs, Ashoka Buildcon, JSW Energy, Aurobindo Pharma, Power... - Moneycontrol.comGoogle News, NIFTY/SENSEX·35d★ ON YOUR LIST
Nifty 50, Sensex May Open Muted Ahead of RBI Policy; Titan, Aurobindo Pharma, Groww in Focus - Dalal Street Investment JournalGoogle News, India stocks·36d★ ON YOUR LIST
Stocks to Watch Today: Aurobindo Pharma, Panacea Biotec, InterGlobe Aviation, CG Power Industrial,... - Moneycontrol.comVERIFIEDET Stocks·36d★ ON YOUR LIST
Stocks in news: Rajesh Exports, Lenskart, Suzlon Energy, Aurobindo Pharma, Tata MotorsAI summary· NEUTRAL
- ·SoftBank has reduced its stake in Lenskart.
- ·Sebi has issued an interim order against Rajesh Exports.
- ·Tata Motors has revised its Avinya EV strategy.
VERIFIEDET Markets·36d★ ON YOUR LIST
Stocks in news: Rajesh Exports, Lenskart, Suzlon Energy, Aurobindo Pharma, Tata MotorsAI summary· NEUTRAL
- ·SoftBank has reduced its stake in Lenskart.
- ·Sebi has issued an interim order against Rajesh Exports.
- ·Tata Motors has revised its Avinya EV strategy.
VERIFIEDET Finance·37d★ ON YOUR LIST
Aurobindo Pharma enters biologics contract manufacturing with Rs 1,200-crore Telangana facilityAI summary· POSITIVE
- ·Aurobindo Pharma has launched TheraNym, a biologics manufacturing plant in Telangana.
- ·The facility will produce biologic medicines for global markets, with US pharma giant MSD as the first major client.
- ·The plant represents an expansion into biologics and contract manufacturing and is expected to create over 1,500 jobs.
VERIFIEDMint Markets·46d★ ON YOUR LIST
Stocks to watch today: Hindalco, TVS Motor, Eicher Motors, NTPC, among stocks in focus on 25 May 2026AI summary· NEUTRAL
- ·Hindalco, TVS Motor, Eicher Motors, and NTPC are among the stocks to watch today.
- ·Lupin, Aurobindo Pharma, and Torrent Pharmaceuticals are also in focus.
- ·Colgate-Palmolive (India), Camlin Fine Sciences, Groww, and Tata Capital are other stocks in focus.
VERIFIEDET Markets·49d★ ON YOUR LIST
Rahul Shah bullish on pharma, sees Sun Pharma and Aurobindo as key large-cap playsAI summary· POSITIVE
- ·Indian equity markets show a mixed but improving consumption trend.
- ·Page Industries is highlighted as a strong recovery story, while Nykaa and Honasa are viewed cautiously.
- ·The pharma sector continues its outperformance, with Sun Pharma and Aurobindo Pharma looking attractive.
Google News, India stocks·54d★ ON YOUR LIST
Stocks to Watch Today: Emcure, Aurobindo Pharma, HFCL, RBL Bank, Coal India, Tata Steel, ITC Hotels, Power Grid, Godfrey Phillips in focus on 18 May - Moneycontrol.comGoogle News, India stocks·54d★ ON YOUR LIST
Stocks to Watch Today: Emcure, Aurobindo Pharma, HFCL, RBL Bank, Coal India, Tata Steel, ITC Hotels, Power... - Moneycontrol.comGoogle News, SEBI·55d★ ON YOUR LIST
Telangana High Court Dismisses Aurobindo Pharma Promoters' Writ Petition Against SEBI's Profit Deposit Directive - scanx.trade